Ann: Collaboration with Little Green Pharma Ltd, page-125

I've invested in several biotechs / technology companies over the years and come to the conclusion that most people invested in them don't have anywhere near the patience to go on what is usually a 5-10 year journey just to get cash-flow positive (assuming they don't go bust on the way).

There are people here who obviously should have invested somewhere else.

The ASX treats such companies almost with disdain because (nearly) everyone is looking for a more immediate return.

It's subsequently no wonder the institutions leave stocks such as OBJ alone.

I'm more than happy to be in this stock even given the significant losses incurred to date.